2 Biotech Cos., Payday Lender Tap IPO Market For $307M

Law360, New York (December 7, 2017, 3:37 PM EST) -- Two venture-backed biotechnology firms and a private-equity backed payday lender raised a combined $307 million from initial public offerings — pricing at the middle or bottom of their respective ranges — while another life science company upsized its planned IPO on Thursday.

Odonate Therapeutics Inc.and Quanterix Corp. saw shares begin trading with mixed results, while Denali Therapeutics Inc. increased the amount of shares for an estimated $250 million IPO that was expected to price after markets closed Thursday. Curo Group Holdings Corp., a lender that targets...
To view the full article, register now.